Donor MHC and adhesion molecules in transplant arteriosclerosis

Journal of Clinical Investigation

Volumn 103, Issue 4, 1999, Pages 469-474

  Shi, Chengwei ^a,e   Feinberg, Mark W ^a   Zhang, Dorothy ^a   Patel, Anand ^a   Sim, Chang U ^a   Dong, Zhao Ming ^b,c   Chapman, Susan M ^b   Gutierrez Ramos, Jose Carlos ^b,c,f   Wagner, Denisa D ^b,c   Sibinga, Nicholas E S ^a,c,d   Haber, Edgar ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTER FOR BLOOD RESEARCH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

^f MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PADGEM PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; HELPER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; TRANSPLANTATION;

EID: 0033557204     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4584     Document Type: Article

References (43)

1. Sharples, L.D., et al. 1991. Risk factor analysis for the major hazards following heart transplantation rejection, infection, and coronary occlusive disease. Transplantation. 52:244-252.
2. Billingham, M.E. 1989. Graft coronary disease: the lesions and the patients. Transplant. Proc. 21:3665-3666.
3. Sarris, G.E., et al. 1994. Cardiac transplantation: the Stanford experience in the cyclosporine era. J. Thorac. Cardiovasc. Surg. 108:240-252.
4. Billingham, M.E. 1995. Pathology of human cardiac transplantation. Monogr. Pathol. 37:108-128.
5. Hornick, P., et al. 1997. Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of 'early' transplant-associated coronary artery disease. Circulation. 96:148-153.
6. Libby, P., Salomon, R.N., Payne, D.D., Schoen, F.J., and Pober, J.S. 1989. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant. Proc. 21:3677-3684.
7. Duquesnoy, R.J., and Demetris, A.J. 1995. Immunopathology of cardiac transplant rejection. Curr. Opin. Cardiol. 10:193-206.
8. Hornick, P., and Lechler, R. 1997. Direct and indirect pathways of alloantigen recognition: relevance to acute and chronic allograft rejection. Nephrol. Dialysis Transplant. 12:1806-1810.
9. Salom, R.N., Maguire, J.A., and Hancock, W.W. 1998. Endothelial activation and cytokine expression in human acute cardiac allograft rejection. Pathology. 30:24-29.
10. Libby, P., and Tanaka, H. 1994. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts. Clin. Transplant. 8:313-318.
11. Heemann, U.W., Tullius, S.G., Azuma, H., Kupiec-Weglinsky, J., and Tilney, N.L. 1994. Adhesion molecules and transplantation. Ann. Surg. 219:4-12.
12. Vestweber, D. 1992. Selectins: cell surface lectins which mediate the binding of leukocytes to endothelial cells. Semin. Cell Biol. 3:211-220.
13. Mayadas, T.N., Johnson, R.C., Rayburn, H., Hynes, R.O., and Wagner, D.D. 1993. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 74:541-554.
14. Johnson, R.C., et al. 1995. Blood cell dynamics in P-selectin-deficient mice. Blood. 86:1106-1114.
15. Xu, H., et al. 1994. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 180:95-109.
16. Schwartz, S.M. 1997. Smooth muscle migration in vascular development and pathogenesis. Transplant Immunol. 5:255-260.
17. Isobe, M., Yagita, H., Okumura, K., and Ihara, A. 1992. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1 Science. 255:1125-1127.
18. Suzuki, J., et al. 1997. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation. J. Heart Lung Transplant. 16:1141-1148.
19. Murphy, B., Kim, K.S., Buelow, R., Sayegh, M.H., and Hancock, W.W. 1997. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis Fischer 344 model of chronic allograft rejection. Transplantation. 64:14-19.
20. Shi, C., Russell, M.E., Bianchi, C., Newell, J.B., and Haber, E. 1994. Murine model of accelerated transplant arteriosclerosis. Circ. Res. 75:199-207.
21. Shi, C., et al. 1996. Immunologic basis of transplant-associated arteriosclerosis. Proc. Natl. Acad. Sci. USA. 93:4051-4056.
22. Allen, M.D., et al. 1992. Endothelial adhesion molecules in heart transplantation. J. Heart Lung Transplant. 11:8s-13s.
23. Jang, Y., Lincoff, A.M., Plow, E.F., and Topol, E.J. 1994. Cell adhesion molecules in coronary artery disease. J. Am. Coll. Cardiol. 24:1591-1601.
24. Ley, K. 1996. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc. Res. 32:733-742.
25. Tullius, S.G., and Tilney, N.L. 1995. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation. 59:313-318.
26. Liu, Z., et al. 1993. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J. Exp. Med. 177:1643-1650.
27. Shoskes, D.A., and Wood, K.J. 1994. Indirect presentation of MHC antigens in transplantation. Immunol. Today. 15:32-38.
28. Steinhoff, G., Wonigeit, K., Schafers, H.J., and Haverich, A. 1989. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens. J. Heart Transplant. 8:360-370.
29. Hasegawa, S., Becker, G., Nagano, H., Libby, P., and Mitchell, R.N. 1998. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Am. J. Pathol. 153:69-79.
30. Timonen, T. 1997. Natural killer cells: endothelial interactions, migration, and target cell recognition. J. Leukocyte Biol. 62:693-701.
31. Robertson, M.J., and Ritz, J. 1990. Biology and clinical relevance of human natural killer cells. Blood. 76:2421-2438.
32. Dong, C., et al. 1996. The pathogenesis of cardiac allograft vasculopathy. Curr. Opin. Cardiol. 11:183-190.
33. Janeway, C.A., Jr., and Travers, P. 1997. Immunobiology: the immune system in health and disease. Current Biology/Garland Publishing. London, United Kingdom/San Francisco, CA/New York, NY. 9:30-9:33.
34. Pamer, E., and Cresswell, P. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323-358.
35. Markmann, J.F., et al. 1992. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation. 54:1085-1089.
36. Fyfe, A.I. 1992. Transplant atherosclerosis: the clinical syndrome, pathogenesis and possible model of spontaneous atherosclerosis. Can. J. Cardiol. 8:509-519.
37. Cramer, D.V., et al. 1992. Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis. J. Heart Lung Transplant. 11:458-466.
38. Tanio, J.W., Basu, C.B., Albelda, S.M., and Eisen, H.J. 1994. Differential expression of the cell adhesion molecules ICAM-1, VCAM-1, and E-selectin in normal and posttransplantation myocardium. Cell adhesion molecule expression in human cardiac allografts. Circulation. 89:1760-1768.
39. Oppenheimer-Marks, N., Davis, L.S., Bogue, D.T., Ramberg, J., and Lipsky, P.E. 1991. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J. Immunol. 147:2913-2921.
40. van de Stolpe, A., and van der Saag, P.T. 1996. Intercellular adhesion molecule-1. J. Mol. Med. 74:13-33.
41. Frenette, P.S., and Wagner, D.D. 1997. Insights into selectin function from knockout mice. Thromb. Haemostasis. 78:60-64.
42. Johnson, R.C., et al. 1997. Absence of P-selectin delays fatty streak formation in mice. J. Clin. Invest. 99:1037-1043.
43. Labarrere, C.A., Nelson, D.R., and Faulk, W.P. 1997. Endothelial activation and development of coronary artery disease in transplanted human hearts. JAMA. 278:1169-1175.